Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 1.28% | 89.78 | 1.3% | $814.23m | |
| AMGN | Amgen Inc. | 1.28% | 187.88 | 1.2% | $637.06m | |
| GILD | Gilead Sciences, Inc. | 0.26% | 65.72 | 0.9% | $483.54m | |
| BIIB | Biogen Inc. | 0.74% | 323.56 | 1.3% | $430.62m | |
| ILMN | Illumina, Inc. | 1.60% | 301.63 | 3.5% | $316.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.93% | 422.51 | 2.6% | $292.88m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.84% | 184.60 | 1.9% | $255.72m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.89% | 128.69 | 2.0% | $221.64m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.21% | 138.19 | 15.4% | $154.17m | |
| A | Agilent Technologies, Inc. | 0.13% | 77.99 | 1.6% | $151.00m | |
| EXAS | Exact Sciences Corporation | 7.63% | 89.63 | 25.3% | $142.36m | |
| INCY | Incyte Corporation | 1.08% | 84.23 | 2.5% | $113.14m | |
| ARRY | Array BioPharma Inc. | 3.43% | 23.49 | 8.2% | $111.72m | |
| EXEL | Exelixis, Inc. | 0.80% | 21.39 | 6.4% | $82.72m | |
| NBIX | Neurocrine Biosciences, Inc. | 1.21% | 78.25 | 5.1% | $78.16m |
Company Profile
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.